"Astellas" is among the top 20 pharmaceutical companies of the world.

Young and prospective company "Astellas" is dedicated towards improving the life quality of people by providing new trustful medicines.

Launched in 2005, "Astellas" was formed through the historical merger of Japan's largest pharmaceutical companies - "Yamanouchi" and "Fujisawa".

"Astellas" purposefully continues to develop first-class drugs in a number of fields of medicine.

"Astellas" in mainly focused on the following areas of medicine: transplantology, urology, infections and pain therapy.